Zwitserland - Italiaans - Swissmedic (Swiss Agency for Therapeutic Products)

eli lilly (suisse) sa - abemaciclibum - compresse filmate - abemaciclibum 150 mg, excipiens pro driver obducto. - cancer du sein précoce - synthetika

Zwitserland - Italiaans - Swissmedic (Swiss Agency for Therapeutic Products)

eli lilly (suisse) sa - abemaciclibum - compresse filmate - abemaciclibum 200 mg, excipiens pro driver obducto. - cancer du sein précoce - synthetika

Europese Unie - Italiaans - EMA (European Medicines Agency)

stemline therapeutics b.v. - elacestrant - neoplasie al seno - terapia endocrina - orserdu monotherapy is indicated for the treatment of postmenopausal women, and men, with estrogen receptor (er) positive, her2-negative, locally advanced or metastatic breast cancer with an activating esr1 mutation who have disease progression following at least one line of endocrine therapy including a cdk 4/6 inhibitor.